Skip to content
2000
Volume 6, Issue 4
  • ISSN: 2666-7967
  • E-ISSN: 2666-7975

Abstract

Background

The devastating outcomes of the Coronavirus Disease (COVID-19) outbreak have traumatized the world, as they are highly infectious and deliberately damage the respiratory tract. Although pregnant women are not at a higher risk of infection, this may result in more severe consequences than in the general population.

Method

The Treatment of COVID-19 in pregnant women is challenging for doctors, as they need to consider the safety of both the mother and fetus. In addition, there is a lack of knowledge regarding the safety, effectiveness, and possible adverse outcomes of drugs used in COVID-19 pregnant women because they are frequently excluded from clinical trials.

Results

We briefly reviewed the pathophysiology; drugs currently being used in the treatment of COVID-19 in pregnant women prohibited certain medications contraindicated during pregnancy. The safety of these drugs originates from small case studies or clinical trials of other diseases.

Conclusion

This study may be useful for medical professionals, related researchers, and people interested in COVID-19 treatment.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/covid/10.2174/0126667975291684240528100603
2024-07-02
2025-10-03

  • From This Site

    /content/journals/covid/10.2174/0126667975291684240528100603
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CucinottaD. VanelliM. WHO declares COVID-19 a Pandemic.Acta Biomed.2020911157160
     [Google Scholar]
  2. World Health Organisation (WHO) https://COVID19.who.int/ (Accessed Oct 1, 2021).
  3. ZhaoX. JiangY. ZhaoY. Analysis of the susceptibility to COVID-19 in pregnancy and recommendations on potential drug screening.Eur. J. Clin. Microbiol. Infect. Dis.20203971209122010.1007/s10096‑020‑03897‑6 32328850
     [Google Scholar]
  4. OuassouH. KharchoufaL. BouhrimM. The pathogenesis of coronavirus disease 2019 (COVID-19): Evaluation and prevention.J. Immunol. Res.202020201710.1155/2020/1357983 32671115
     [Google Scholar]
  5. MorG. CardenasI. The immune system in pregnancy: A unique complexity.Am. J. Reprod. Immunol.201063642543310.1111/j.1600‑0897.2010.00836.x 20367629
     [Google Scholar]
  6. HuangC. WangY. LiX. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.Lancet20203951022349750610.1016/S0140‑6736(20)30183‑5 31986264
     [Google Scholar]
  7. HarapanH. ItohN. YufikaA. Coronavirus disease 2019 (COVID-19): A literature review.J. Infect. Public Health202013566767310.1016/j.jiph.2020.03.019 32340833
     [Google Scholar]
  8. LiuH. WangL.L. ZhaoS.J. Kwak-KimJ. MorG. LiaoA.H. Why are pregnant women susceptible to COVID-19? An immunological viewpoint.J. Reprod. Immunol.202013910312210.1016/j.jri.2020.103122 32244166
     [Google Scholar]
  9. AghaeepourN. GanioE.A. McilwainD. An immune clock of human pregnancy.Sci. Immunol.2017215eaan294610.1126/sciimmunol.aan2946 28864494
     [Google Scholar]
  10. MorG. AldoP. AlveroA.B. The unique immunological and microbial aspects of pregnancy.Nat. Rev. Immunol.201717846948210.1038/nri.2017.64 28627518
     [Google Scholar]
  11. AskaryE. TaherehP. ShiravaniZ. Coronavirus disease 2019 (COVID-19) manifestations during pregnancy in all three trimesters: A case series.Int. J. Reprod. Biomed.202119219120410.18502/ijrm.v19i2.8477 33718763
     [Google Scholar]
  12. Berghella, Vincenzo, and Brenna Hughes. COVID-19: Pregnancy issues and antenatal care. https://www.uptodate.com/contents/COVID-19-pregnancy-issues-and-antenatalcare/print?sectionName=Pregnancy%20and%20newborn%20outcom (Accessed July 15, 2021.).
  13. Di MascioD. SenC. SacconeG. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 [published correction appears in J Perinat Med. 2020 Dec 02;49(1):111-115.J. Perinat. Med.202048995095810.1515/jpm‑2020‑0355 32975205
     [Google Scholar]
  14. SukhikhG. PetrovaU. PrikhodkoA. Vertical Transmission of SARS-CoV-2 in second trimester associated with severe neonatal pathology.Viruses202113344710.3390/v13030447 33801923
     [Google Scholar]
  15. FavreG. PomarL. MussoD. BaudD. 2019-nCoV epidemic: What about pregnancies?Lancet202039510224e4010.1016/S0140‑6736(20)30311‑1 32035511
     [Google Scholar]
  16. MamunM.M.A. KhanM.R. COVID-19 Delta variant-of-concern: A real concern for pregnant women with gestational diabetes mellitus.Front. Endocrinol.20211277891110.3389/fendo.2021.778911 34867825
     [Google Scholar]
  17. HeZ. LvY. ZhengS. Association of COVID-19 lockdown with gestational diabetes mellitus.Front. Endocrinol.20221382424510.3389/fendo.2022.824245 35432191
     [Google Scholar]
  18. DwivediJ. YadavS. Advents in contraception: immunocontraception.Int J Therap Applic20121519
     [Google Scholar]
  19. ZambranoL.D. EllingtonS. StridP. Update: Characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status United States, January 22–October 3, 2020.MMWR Morb. Mortal. Wkly. Rep.202069441641164710.15585/mmwr.mm6944e3 33151921
     [Google Scholar]
  20. MendozaM. Garcia-RuizI. MaizN. Pre‐eclampsia‐like syndrome induced by severe COVID‐19: A prospective observational study.BJOG2020127111374138010.1111/1471‑0528.16339 32479682
     [Google Scholar]
  21. AghaamooS. GhodsK. RahmanianM. Pregnant women with COVID-19: The placental involvement and consequences.J. Mol. Histol.202152342743510.1007/s10735‑021‑09970‑4 33871721
     [Google Scholar]
  22. OsuchowskiM.F. WinklerM.S. SkireckiT. The COVID-19 puzzle: Deciphering pathophysiology and phenotypes of a new disease entity.Lancet Respir. Med.20219662264210.1016/S2213‑2600(21)00218‑6 33965003
     [Google Scholar]
  23. ParasherA. COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment.Postgrad. Med. J.202197114731232010.1136/postgradmedj‑2020‑138577 32978337
     [Google Scholar]
  24. SandersJ.M. MonogueM.L. JodlowskiT.Z. CutrellJ.B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19).JAMA2020323181824183610.1001/jama.2020.6019 32282022
     [Google Scholar]
  25. WangX. WangD. HeS. The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy.Am. J. Obstet. Gynecol.2020223578078210.1016/j.ajog.2020.07.010 32659225
     [Google Scholar]
  26. ChenG. LiaoQ. AiJ. Immune response to COVID-19 during pregnancy.Front. Immunol.20211267547610.3389/fimmu.2021.675476 34012458
     [Google Scholar]
  27. GoudarziS. FirouzabadiF.D. MahmoudzadehF. AminimoghaddamS. Pulmonary embolism in pregnancy with COVID‐19 infection: A case report.Clin. Case Rep.2021941882188610.1002/ccr3.3709 33821188
     [Google Scholar]
  28. MullinsE. EvansD. VinerR.M. O’BrienP. MorrisE. Coronavirus in pregnancy and delivery: Rapid review.Ultrasound Obstet. Gynecol.202055558659210.1002/uog.22014 32180292
     [Google Scholar]
  29. ChenL. LiQ. ZhengD. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China.N. Engl. J. Med.202038225e10010.1056/NEJMc2009226 32302077
     [Google Scholar]
  30. MorelliS. MandalM. GoldsmithL.T. KashaniB.N. PonzioN.M. The maternal immune system during pregnancy and its influence on fetal development.Res. Rep. Biol.2015617118910.2147/RRB.S80652
     [Google Scholar]
  31. MorG. CardenasI. AbrahamsV. GullerS. Inflammation and pregnancy: The role of the immune system at the implantation site.Ann. N. Y. Acad. Sci.201112211808710.1111/j.1749‑6632.2010.05938.x 21401634
     [Google Scholar]
  32. ZhangL. JiangY. WeiM. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province.Zhonghua Fu Chan Ke Za Zhi2020553166171 32145714
     [Google Scholar]
  33. LiuD. LiL. WuX. Pregnancy and perinatal outcomes of women with coronavirus disease (COVID-19) pneumonia: A preliminary analysis.AJR Am. J. Roentgenol.2020215112713210.2214/AJR.20.23072 32186894
     [Google Scholar]
  34. ChenR. ZhangY. HuangL. ChengB. XiaZ. MengQ. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: A case series of 17 patients.Can. J. Anaesth.202067665566310.1007/s12630‑020‑01630‑7 32180175
     [Google Scholar]
  35. ChenS. HuangB. LuoD.J. Pregnant women with new coronavirus infection: A clinical characteristics and placental pathological analysis of three cases.Zhonghua Bing Li Xue Za Zhi202049E005
     [Google Scholar]
  36. ZhuH. WangL. FangC. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia.Transl. Pediatr.202091516010.21037/tp.2020.02.06 32154135
     [Google Scholar]
  37. WangX. ZhouZ. ZhangJ. ZhuF. TangY. ShenX. A case of 2019 novel coronavirus in a pregnant woman with preterm delivery.Clin. Infect. Dis.2020711584484610.1093/cid/ciaa200 32119083
     [Google Scholar]
  38. WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance 13 March 20.https://apps.who.int/iris/handle/10665/331446
  39. WangM. CaoR. ZhangL. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.Cell Res.202030326927110.1038/s41422‑020‑0282‑0 32020029
     [Google Scholar]
  40. ZhouD. DaiS.M. TongQ. COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression.J. Antimicrob. Chemother.20207571667167010.1093/jac/dkaa114 32196083
     [Google Scholar]
  41. KlumppT.G. Safety of chloroquine in pregnancy.JAMA1965191976510.1001/jama.1965.03080090079027
     [Google Scholar]
  42. KalilA.C. Treating COVID-19—off-label drug use, compassionate use, and randomized clinical trials during pandemics.JAMA2020323191897189810.1001/jama.2020.4742 32208486
     [Google Scholar]
  43. TripathyS. DassarmaB. RoyS. ChabalalaH. MatsabisaM.G. A review on possible modes of action of chloroquine/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic.Int. J. Antimicrob. Agents202056210602810.1016/j.ijantimicag.2020.106028 32450198
     [Google Scholar]
  44. JavelotH. El-HageW. MeyerG. BeckerG. MichelB. HingrayC. COVID‐19 and (hydroxy)chloroquine–azithromycin combination: Should we take the risk for our patients?Br. J. Clin. Pharmacol.20208661176117710.1111/bcp.14335 32350872
     [Google Scholar]
  45. CaoB. WangY. WenD. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19.N. Engl. J. Med.2020382191787179910.1056/NEJMoa2001282 32187464
     [Google Scholar]
  46. ChuC.M. ChengV.C. HungI.F. Role of lopinavir/ritonavir in the treatment of SARS: Initial virological and clinical findings.Thorax200459325225610.1136/thorax.2003.012658 14985565
     [Google Scholar]
  47. GordonC.J. TchesnokovE.P. WoolnerE. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.J. Biol. Chem.2020295206785679710.1074/jbc.RA120.013679 32284326
     [Google Scholar]
  48. UKTISMedications used to treat COVID-19 in pregnancy. https://www.medicinesinpregnancy.org/bumps/monographs/MEDICATIONS-USED-TO-TREAT-COVID-19-IN-PREGNANCY/ (Accessed June 25, 2021.).
     [Google Scholar]
  49. LampejoT. Remdesivir for the treatment of COVID‐19 in pregnancy.J. Med. Virol.20219374114411910.1002/jmv.26986 33788273
     [Google Scholar]
  50. ManyA. KorenG. Low-molecular-weight heparins during pregnancy.Can. Fam. Physician2005512199201 15751560
     [Google Scholar]
  51. SiddiqiH.K. MehraM.R. COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal.J. Heart Lung Transplant.202039540540710.1016/j.healun.2020.03.012 32362390
     [Google Scholar]
  52. D’SouzaR. MalhaméI. TeshlerL. AcharyaG. HuntB.J. McLintockC. A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID‐19.Acta Obstet. Gynecol. Scand.20209991110112010.1111/aogs.13962 32678949
     [Google Scholar]
  53. RobertsS.S. MartinezM. CovingtonD.L. RodeR.A. PasleyM.V. WoodwardW.C. Lopinavir/ritonavir in pregnancy.J. Acquir. Immune Defic. Syndr.200951445646110.1097/QAI.0b013e3181a2813f 19381099
     [Google Scholar]
  54. SieswerdaE. de BoerM.G.J. BontenM.M.J. Recommendations for antibacterial therapy in adults with COVID-19: An evidence based guideline.Clin. Microbiol. Infect.2021271616610.1016/j.cmi.2020.09.041 33010444
     [Google Scholar]
  55. NorooznezhadA.H. HantoushzadehS. ShamshirsazA.A. Empiric antibiotics in management of inpatient pregnant women infected with coronavirus disease 2019 (COVID-19): Focusing on inflammation and preterm labor.Med. Hypotheses202014411026910.1016/j.mehy.2020.110269 33254573
     [Google Scholar]
  56. PaniA. LauriolaM. RomandiniA. ScaglioneF. Macrolides and viral infections: focus on azithromycin in COVID-19 pathology.Int. J. Antimicrob. Agents202056210605310.1016/j.ijantimicag.2020.106053 32534189
     [Google Scholar]
  57. ElsawahH.K. ElsokaryM.A. AbdallahM.S. ElShafieA.H. Efficacy and safety of remdesivir in hospitalized Covid‐19 patients: Systematic review and meta‐analysis including network meta‐analysis.Rev. Med. Virol.2021314e218710.1002/rmv.2187 33128490
     [Google Scholar]
  58. ParnhamM.J. HaberV.E. Giamarellos-BourboulisE.J. PerlettiG. VerledenG.M. VosR. Azithromycin: Mechanisms of action and their relevance for clinical applications.Pharmacol. Ther.2014143222524510.1016/j.pharmthera.2014.03.003 24631273
     [Google Scholar]
  59. ZimmermannP. ZiesenitzV.C. CurtisN. RitzN. The immunomodulatory effects of macrolides—A systematic review of the underlying mechanisms.Front. Immunol.2018930210.3389/fimmu.2018.00302 29593707
     [Google Scholar]
  60. ACOG Committee Opinion No743 Summary: Low-Dose Aspirin Use During Pregnancy.Obstet. Gynecol.20181321254256
     [Google Scholar]
  61. KwiatkowskiS. BorowskiD. KajdyA. PoonL.C. RokitaW. WielgosM. Why we should not stop giving aspirin to pregnant women during the COVID‐19 pandemic.Ultrasound Obstet. Gynecol.202055684184310.1002/uog.22049 32304612
     [Google Scholar]
  62. LuoP. LiuY. QiuL. LiuX. LiuD. LiJ. Tocilizumab treatment in COVID‐19: A single center experience.J. Med. Virol.202092781481810.1002/jmv.25801 32253759
     [Google Scholar]
  63. NaqviM. ZakowskiP. GlucksmanL. SmithsonS. BurwickR.M. Tocilizumab and remdesivir in a pregnant patient with coronavirus disease 2019 (COVID-19).Obstet. Gynecol.202013651025102910.1097/AOG.0000000000004050 32618794
     [Google Scholar]
  64. Haji AbdolvahabM. Moradi-kalbolandiS. ZareiM. BoseD. Majidzadeh-AK. FarahmandL. Potential role of interferons in treating COVID-19 patients.Int. Immunopharmacol.20219010717110.1016/j.intimp.2020.107171 33221168
     [Google Scholar]
  65. Yazdani BrojeniP. MatokI. Garcia BournissenF. KorenG. A systematic review of the fetal safety of interferon alpha.Reprod. Toxicol.201233326526810.1016/j.reprotox.2011.11.003 22200624
     [Google Scholar]
  66. RomeroR.S. LünzmannC. BuggeJ.P. Pregnancy outcomes in patients exposed to interferon beta-1b: Table 1.J. Neurol. Neurosurg. Psychiatry201586558758910.1136/jnnp‑2014‑308113 25185209
     [Google Scholar]
  67. DwivediJ. WalP. DashB. OvaisM. SachanP. VermaV. Diabetic pneumopathy a novel diabetes-associated complication: Pathophysiology, the underlying mechanism and combination medication.Endocr. Metab. Immune Disord. Drug Targets20232310.2174/0118715303265960230926113201 37817659
     [Google Scholar]
  68. HellwigK. GeissbuehlerY. SabidóM. Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the european interferon-beta pregnancy registry.J. Neurol.202026761715172310.1007/s00415‑020‑09762‑y 32100126
     [Google Scholar]
  69. DuanK. LiuB. LiC. Effectiveness of convalescent plasma therapy in severe COVID-19 patients.Proc. Natl. Acad. Sci.2020117179490949610.1073/pnas.2004168117 32253318
     [Google Scholar]
  70. ChenL. XiongJ. BaoL. ShiY. Convalescent plasma as a potential therapy for COVID-19.Lancet Infect. Dis.202020439840010.1016/S1473‑3099(20)30141‑9 32113510
     [Google Scholar]
  71. AndersonJ. SchauerJ. BryantS. GravesC.R. The use of convalescent plasma therapy and remdesivir in the successful management of a critically ill obstetric patient with novel coronavirus 2019 infection: A case report.Case Rep. Womens Health202027e0022110.1016/j.crwh.2020.e00221 32426243
     [Google Scholar]
  72. LiG. ZhaoS. CuiS. LiL. XuY. LiY. Effect comparison of metformin with insulin treatment for gestational diabetes: A meta-analysis based on RCTs.Arch. Gynecol. Obstet.2015292111112010.1007/s00404‑014‑3566‑0 25547060
     [Google Scholar]
  73. GilbertC. ValoisM. KorenG. Pregnancy outcome after first-trimester exposure to metformin: A meta-analysis.Fertil. Steril.200686365866310.1016/j.fertnstert.2006.02.098 16879826
     [Google Scholar]
  74. Medical News TodayCan I use Metformin during pregnancy? https://www.medicalnewstoday.com/articles/317397(Accessed June 27,2021).
     [Google Scholar]
  75. ZangiabadianM. NejadghaderiS.A. ZahmatkeshM.M. HajikhaniB. MirsaeidiM. NasiriM.J. The efficacy and potential mechanisms of metformin in the treatment of COVID-19 in the Diabetics: A systematic review.Front. Endocrinol.20211264519410.3389/fendo.2021.645194 33815295
     [Google Scholar]
  76. CarboniE. CartaA.R. CarboniE. Can pioglitazone be potentially useful therapeutically in treating patients with COVID-19?Med. Hypotheses202014010977610.1016/j.mehy.2020.109776 32344313
     [Google Scholar]
  77. OtaH. GotoT. YoshiokaT. OhyamaN. Successful pregnancies treated with pioglitazone in infertile patients with polycystic ovary syndrome.Fertil. Steril.200890370971310.1016/j.fertnstert.2007.01.117 18423625
     [Google Scholar]
  78. XieX. SinhaS. YiZ. Role of adipocyte mitochondria in inflammation, lipemia and insulin sensitivity in humans: effects of pioglitazone treatment.Int. J. Obes.2017 29087390
     [Google Scholar]
  79. Magala SsekandiA. SserwanjaQ. OlalE. KawukiJ. Bashir AdamM. Corticosteroids use in pregnant women with COVID-19: Recommendations from Available Evidence.J. Multidiscip. Healthc.20211465966310.2147/JMDH.S301255 33758509
     [Google Scholar]
  80. Coronavirus (COVID-19) infection and pregnancy. Royal College of Obstetricians & Gynaecologists. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/coronavirus-pregnancy/ (Accessed June 4, 2021).
  81. CavalcanteM.B. CavalcanteC.T.M.B. BragaA.C.S. COVID-19 Treatment: drug safety prior to conception and during pregnancy and breastfeeding.Geburtshilfe Frauenheilkd.2021811466010.1055/a‑1247‑5271 33487665
     [Google Scholar]
  82. TodaK. Is acetaminophen safe in pregnancy?Scand. J. Pain201717144544610.1016/j.sjpain.2017.09.007 28986045
     [Google Scholar]
  83. Prednisolone Use During Pregnancy, Drugs.com https://www.drugs.com/pregnancy/prednisolone.html (Accessed June 27, 2021).
  84. GiampretiA. EleftheriouG. GalloM. Medications prescriptions in COVID-19 pregnant and lactating women: the Bergamo Teratology Information Service experience during COVID-19 outbreak in Italy.J. Perinat. Med.20204891001100710.1515/jpm‑2020‑0339 33055313
     [Google Scholar]
  85. SistiG. SchiattarellaA. SistiA. Treatment of COVID-19 in Pregnancy with Hydroxychloroquine and Azithromycin: A case report.Acta Biomed.2020914e2020123 33525254
     [Google Scholar]
  86. SavasiV.M. ParisiF. PatanèL. Clinical findings and disease severity in hospitalized pregnant women with coronavirus disease 2019 (COVID-19).Obstet. Gynecol.2020136225225810.1097/AOG.0000000000003979 32433453
     [Google Scholar]
  87. XuL. YangQ. ShiH. Clinical presentations and outcomes of SARS-CoV-2 infected pneumonia in pregnant women and health status of their neonates.Sci. Bull.202065181537154210.1016/j.scib.2020.04.040 32346493
     [Google Scholar]
  88. MaraschiniA. CorsiE. SalvatoreM.A. DonatiS. ItOSS COVID-19 Working Group. Coronavirus and birth in Italy: results of a national population-based cohort study.medRxiv2020
     [Google Scholar]
  89. WalP. DwivediJ. WalA. KushwahaS. Diabetic patients with COVID-19 Complications: Insights into prevalence, prognosis, combination medications, and underlying mechanisms.Curr. Diabetes Rev.2023197e25082220800810.2174/1573399819666220825164056 36028964
     [Google Scholar]
  90. Health TMo Profile of pregnant and children and adolecents with COVID-192020
  91. BrandtJ.S. HillJ. ReddyA. Epidemiology of coronavirus disease 2019 in pregnancy: risk factors and associations with adverse maternal and neonatal outcomes.Am. J. Obstet. Gynecol.20212244389.e1389.e910.1016/j.ajog.2020.09.043 32986989
     [Google Scholar]
  92. PereiraA. Cruz-MelguizoS. AdrienM. FuentesL. MarinE. Perez-MedinaT. Clinical course of coronavirus disease‐2019 in pregnancy.Acta Obstet. Gynecol. Scand.202099783984710.1111/aogs.13921 32441332
     [Google Scholar]
  93. RCOG Coronavirus (COVID-19) infection in pregnancy2020
  94. Prevention CCfDCa Coronavirus disease 2019 (COVID-19) pregnancy and breastfeeding 2020 932020
  95. FujisakiS. MoriN. SasakiT. MaeyamaM. Cell-mediated immunity in human pregnancy: Changes in lymphocyte reactivity during pregnancy and postpartum.Microbiol. Immunol.1979239899907
     [Google Scholar]
  96. ACOGOutpatient assessment and management for pregnant women with suspected or confirmed novel coronavirus (COVID-19).2020Available from URL: https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/clinical-guidance/practice-advisory/COVID-19-algorithm.pdf?la=en&hash=2D9E7F62C97F8231561616FFDCA3B1
    [Google Scholar]
  97. Guidance for Maternity Services. Version 3.0.2020Available from URL: https://www.rcpi.ie/news/releases/theinstitute-of-obstetricians-and-gynaecologists-issuesguidance-on-COVID-19-and-maternity-services/
  98. KaramiP. NaghaviM. FeyziA. WITHDRAWN: Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings.Travel Med. Infect. Dis.202010166510166510.1016/j.tmaid.2020.101665 32283217
     [Google Scholar]
  99. Di MascioD. KhalilA. SacconeG. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: A systematic review and meta-analysis.Am. J. Obstet. Gynecol. MFM20202210010710.1016/j.ajogmf.2020.100107 32292902
     [Google Scholar]
  100. HantoushzadehS. ShamshirsazA.A. AleyasinA. Maternal death due to COVID-19 disease.Am. J. Obstet. Gynecol.2020202020S0002S937810.1016/j.ajog.2020.04.030
     [Google Scholar]
  101. FerrazziE.M. FrigerioL. CetinI. COVID‐19 Obstetrics Task Force, Lombardy, Italy: Executive management summary and short report of outcome.Int. J. Gynaecol. Obstet.20201493377378b10.1002/ijgo.13162 32267531
     [Google Scholar]
  102. FerrazziE. FrigerioL. SavasiV. Vaginal delivery in SARS‐CoV‐2‐infected pregnant women in Northern Italy: A retrospective analysis.BJOG202012791116112110.1111/1471‑0528.16278 32339382
     [Google Scholar]
  103. ElshafeeyF MagdiR HindiN A systematic scoping review of COVID-19 during pregnancy and childbirth. Int J Gynaecol Obstet. 2020. https://doi.org/10.1002/ijgo.13182. 104. Dennis AT, Hardy L, Leeton L. The prone position in healthy pregnant women and in women with preeclampsia a pilot study.BMC Pregnancy Childbirth201818144510.1002/ijgo.13182
     [Google Scholar]
  104. LinT.T. ZhangC. ZhangH.Q. Thyroid hormone changes in early pregnancy along with the COVID-19 pandemic.Front. Endocrinol.20201160672310.3389/fendo.2020.606723 33365014
     [Google Scholar]
  105. PhelanN. BehanL.A. OwensL. The impact of the COVID-19 pandemic on women’s reproductive health.Front. Endocrinol.20211264275510.3389/fendo.2021.642755 33841334
     [Google Scholar]
/content/journals/covid/10.2174/0126667975291684240528100603
Loading
Pandemic and Pregnancy: A Systematic Review on the Effect of the COVID-19 Drugs on Pregnant Women’s
Coronaviruses 6, E020724231456 (2025); https://doi.org/10.2174/0126667975291684240528100603
/content/journals/covid/10.2174/0126667975291684240528100603
/content/journals/covid/10.2174/0126667975291684240528100603
Loading

Data & Media loading...

Supplements

The PRISMA checklist is available as supplementary material on the publisher’s website along with the published article.

file format download Download

  • Article Type:     Review Article
Keyword(s): Coronavirus; COVID-19; neonates; pathophysiology; pregnancy; SARS

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test